Hepatobiliary cancers include a spectrum of invasive carcinomas arising in the liver (hepatocellular carcinoma), gall bladder, and bile ducts (cholangiocarcinomas). Gallbladder cancer and cholangiocarcinomas are collectively known as biliary tract cancers. Gallbladder cancer is the most common and aggressive type of all the biliary tract cancers. Cholangiocarcinomas are diagnosed throughout the biliary tree and are typically classified as either intrahepatic or extrahepatic cholangiocarcinoma. Extrahepatic cholangiocarcinomas are more common than intrahepatic cholangiocarcinomas. This manuscript focuses on the clinical management of patients with gallbladder cancer and cholangiocarcinomas (intrahepatic and extrahepatic).

  • 1.

    SiegelRMaJZouZJemalA. Cancer statistics, 2014. CA Cancer J Clin2014;64:929.

  • 2.

    DonohueJHStewartAKMenckHR. The National Cancer Data Base report on carcinoma of the gallbladder, 1989-1995. Cancer1998;83:26182628.

  • 3.

    LevyADMurakataLARohrmannCAJr. Gallbladder carcinoma: radiologic-pathologic correlation. Radiographics2001;21:295314; questionnaire 549-255.

    • Search Google Scholar
    • Export Citation
  • 4.

    JarnaginWRRuoLLittleSA. Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: implications for adjuvant therapeutic strategies. Cancer2003;98:16891700.

    • Search Google Scholar
    • Export Citation
  • 5.

    ShethSBedfordAChopraS. Primary gallbladder cancer: recognition of risk factors and the role of prophylactic cholecystectomy. Am J Gastroenterol2000;95:14021410.

    • Search Google Scholar
    • Export Citation
  • 6.

    TazumaSKajiyamaG. Carcinogenesis of malignant lesions of the gall bladder. The impact of chronic inflammation and gallstones. Langenbecks Arch Surg2001;386:224229.

    • Search Google Scholar
    • Export Citation
  • 7.

    KhanZSLivingstonEHHuertaS. Reassessing the need for prophylactic surgery in patients with porcelain gallbladder: case series and systematic review of the literature. Arch Surg2011;146:11431147.

    • Search Google Scholar
    • Export Citation
  • 8.

    SchnelldorferT. Porcelain gallbladder: a benign process or concern for malignancy?J Gastrointest Surg2013;17:11611168.

  • 9.

    ElnemrAOhtaTKayaharaM. Anomalous pancreaticobiliary ductal junction without bile duct dilatation in gallbladder cancer. Hepatogastroenterology2001;48:382386.

    • Search Google Scholar
    • Export Citation
  • 10.

    ReidKMRamos-De la MedinaADonohueJH. Diagnosis and surgical management of gallbladder cancer: a review. J Gastrointest Surg2007;11:671681.

    • Search Google Scholar
    • Export Citation
  • 11.

    EdgeSBByrdDRComptonCC. AJCC Cancer Staging Manual. 7th ed.New York, NY: Springer; 2010.

  • 12.

    FongYWagmanLGonenM. Evidence-based gallbladder cancer staging: changing cancer staging by analysis of data from the National Cancer Database. Ann Surg2006;243:767771; discussion 771-764.

    • Search Google Scholar
    • Export Citation
  • 13.

    DuffyACapanuMAbou-AlfaGK. Gallbladder cancer (GBC): 10-year experience at Memorial Sloan-Kettering Cancer Centre (MSKCC). J Surg Oncol2008;98:485489.

    • Search Google Scholar
    • Export Citation
  • 14.

    ItoHItoKD’AngelicaM. Accurate staging for gallbladder cancer: implications for surgical therapy and pathological assessment. Ann Surg2011;254:320325.

    • Search Google Scholar
    • Export Citation
  • 15.

    HawkinsWGDeMatteoRPJarnaginWR. Jaundice predicts advanced disease and early mortality in patients with gallbladder cancer. Ann Surg Oncol2004;11:310315.

    • Search Google Scholar
    • Export Citation
  • 16.

    FurlanAFerrisJVHosseinzadehKBorhaniAA. Gallbladder carcinoma update: multimodality imaging evaluation, staging, and treatment options. AJR Am J Roentgenol2008;191:14401447.

    • Search Google Scholar
    • Export Citation
  • 17.

    PetrowskyHWildbrettPHusarikDB. Impact of integrated positron emission tomography and computed tomography on staging and management of gallbladder cancer and cholangiocarcinoma. J Hepatol2006;45:4350.

    • Search Google Scholar
    • Export Citation
  • 18.

    CorveraCUBlumgartLHAkhurstT. 18F-fluorodeoxyglucose positron emission tomography influences management decisions in patients with biliary cancer. J Am Coll Surg2008;206:5765.

    • Search Google Scholar
    • Export Citation
  • 19.

    LeeSWKimHJParkJH. Clinical usefulness of 18F-FDG PET-CT for patients with gallbladder cancer and cholangiocarcinoma. J Gastroenterol2010;45:560566.

    • Search Google Scholar
    • Export Citation
  • 20.

    StromBLMaislinGWestSL. Serum CEA and CA 19-9: potential future diagnostic or screening tests for gallbladder cancer?Int J Cancer1990;45:821824.

    • Search Google Scholar
    • Export Citation
  • 21.

    DixonEVollmerCMJrSahajpalA. An aggressive surgical approach leads to improved survival in patients with gallbladder cancer: a 12-year study at a North American Center. Ann Surg2005;241:385394.

    • Search Google Scholar
    • Export Citation
  • 22.

    FuksDRegimbeauJMLe TreutYP. Incidental gallbladder cancer by the AFC-GBC-2009 Study Group. World J Surg2011;35:18871897.

  • 23.

    LeeSEJangJYLimCS. Systematic review on the surgical treatment for T1 gallbladder cancer. World J Gastroenterol2011;17:174180.

  • 24.

    FosterJMHoshiHGibbsJF. Gallbladder cancer: Defining the indications for primary radical resection and radical re-resection. Ann Surg Oncol2007;14:833840.

    • Search Google Scholar
    • Export Citation
  • 25.

    CoburnNGClearySPTanJCLawCH. Surgery for gallbladder cancer: a population-based analysis. J Am Coll Surg2008;207:371382.

  • 26.

    YouDDLeeHGPaikKY. What is an adequate extent of resection for T1 gallbladder cancers?Ann Surg2008;247:835838.

  • 27.

    JensenEHAbrahamAHabermannEB. A critical analysis of the surgical management of early-stage gallbladder cancer in the United States. J Gastrointest Surg2009;13:722727.

    • Search Google Scholar
    • Export Citation
  • 28.

    DowningSRCadoganKAOrtegaG. Early-stage gallbladder cancer in the surveillance, epidemiology, and end results database: effect of extended surgical resection. Arch Surg2011;146:734738.

    • Search Google Scholar
    • Export Citation
  • 29.

    ShiraiYSakataJWakaiT. “Extended” radical cholecystectomy for gallbladder cancer: long-term outcomes, indications and limitations. World J Gastroenterol2012;18:47364743.

    • Search Google Scholar
    • Export Citation
  • 30.

    D’AngelicaMDalalKMDeMatteoRP. Analysis of the extent of resection for adenocarcinoma of the gallbladder. Ann Surg Oncol2009;16:806816.

    • Search Google Scholar
    • Export Citation
  • 31.

    PawlikTMGleisnerALViganoL. Incidence of finding residual disease for incidental gallbladder carcinoma: implications for re-resection. J Gastrointest Surg2007;11:14781486; discussion 1486-1477.

    • Search Google Scholar
    • Export Citation
  • 32.

    FongYJarnaginWBlumgartLH. Gallbladder cancer: comparison of patients presenting initially for definitive operation with those presenting after prior noncurative intervention. Ann Surg2000;232:557569.

    • Search Google Scholar
    • Export Citation
  • 33.

    ShihSPSchulickRDCameronJL. Gallbladder cancer: the role of laparoscopy and radical resection. Ann Surg2007;245:893901.

  • 34.

    AgarwalAKKalayarasanRJavedA. Role of staging laparoscopy in primary gall bladder cancer—an analysis of 409 patients: a prospective study to evaluate the role of staging laparoscopy in the management of gallbladder cancer. Ann Surg2013;258:318323.

    • Search Google Scholar
    • Export Citation
  • 35.

    ButteJMGonenMAllenPJ. The role of laparoscopic staging in patients with incidental gallbladder cancer. HPB (Oxford)2011;13:463472.

  • 36.

    MakerAVButteJMOxenbergJ. Is port site resection necessary in the surgical management of gallbladder cancer?Ann Surg Oncol2012;19:409417.

    • Search Google Scholar
    • Export Citation
  • 37.

    FuksDRegimbeauJMPessauxP. Is port-site resection necessary in the surgical management of gallbladder cancer?J Visc Surg2013;150:277284.

    • Search Google Scholar
    • Export Citation
  • 38.

    RegimbeauJMFuksDBachellierP. Prognostic value of jaundice in patients with gallbladder cancer by the AFC-GBC-2009 study group. Eur J Surg Oncol2011;37:505512.

    • Search Google Scholar
    • Export Citation
  • 39.

    WangSJFullerCDKimJS. Prediction model for estimating the survival benefit of adjuvant radiotherapy for gallbladder cancer. J Clin Oncol2008;26:21122117.

    • Search Google Scholar
    • Export Citation
  • 40.

    WangSJLemieuxAKalpathy-CramerJ. Nomogram for predicting the benefit of adjuvant chemoradiotherapy for resected gallbladder cancer. J Clin Oncol2011;29:46274632.

    • Search Google Scholar
    • Export Citation
  • 41.

    LimJH. Cholangiocarcinoma: morphologic classification according to growth pattern and imaging findings. AJR Am J Roentgenol2003;181:819827.

    • Search Google Scholar
    • Export Citation
  • 42.

    DeOliveiraMLCunninghamSCCameronJL. Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution. Ann Surg2007;245:755762.

    • Search Google Scholar
    • Export Citation
  • 43.

    ChapmanRW. Risk factors for biliary tract carcinogenesis. Ann Oncol1999;10(Suppl 4):308311.

  • 44.

    TysonGLEl-SeragHB. Risk factors for cholangiocarcinoma. Hepatology2011;54:173184.

  • 45.

    DonatoFGelattiUTaggerA. Intrahepatic cholangiocarcinoma and hepatitis C and B virus infection, alcohol intake, and hepatolithiasis: a case-control study in Italy. Cancer Causes Control2001;12:959964.

    • Search Google Scholar
    • Export Citation
  • 46.

    YamamotoSKuboSHaiS. Hepatitis C virus infection as a likely etiology of intrahepatic cholangiocarcinoma. Cancer Sci2004;95:592595.

  • 47.

    ShaibYHEl-SeragHBDavilaJA. Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study. Gastroenterology2005;128:620626.

    • Search Google Scholar
    • Export Citation
  • 48.

    WelzelTMMellemkjaerLGloriaG. Risk factors for intrahepatic cholangiocarcinoma in a low-risk population: a nationwide case-control study. Int J Cancer2007;120:638641.

    • Search Google Scholar
    • Export Citation
  • 49.

    ChangKYChangJYYenY. Increasing incidence of intrahepatic cholangiocarcinoma and its relationship to chronic viral hepatitis. J Natl Compr Canc Netw2009;7:423427.

    • Search Google Scholar
    • Export Citation
  • 50.

    EndoIGonenMYoppAC. Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection. Ann Surg2008;248:8496.

    • Search Google Scholar
    • Export Citation
  • 51.

    NathanHAloiaTAVautheyJN. A proposed staging system for intrahepatic cholangiocarcinoma. Ann Surg Oncol2009;16:1422.

  • 52.

    de JongMCNathanHSotiropoulosGC. Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment. J Clin Oncol2011;29:31403145.

    • Search Google Scholar
    • Export Citation
  • 53.

    FargesOFuksDLe TreutYP. AJCC 7th edition of TNM staging accurately discriminates outcomes of patients with resectable intrahepatic cholangiocarcinoma. Cancer2011;117:21702177.

    • Search Google Scholar
    • Export Citation
  • 54.

    de JongMCHongSMAugustineMM. Hilar cholangiocarcinoma: tumor depth as a predictor of outcome. Arch Surg2011;146:697703.

  • 55.

    HongSMPawlikTMChoH. Depth of tumor invasion better predicts prognosis than the current American Joint Committee on Cancer T classification for distal bile duct carcinoma. Surgery2009;146:250257.

    • Search Google Scholar
    • Export Citation
  • 56.

    BismuthHNakacheRDiamondT. Management strategies in resection for hilar cholangiocarcinoma. Ann Surg1992;215:3138.

  • 57.

    JarnaginWRFongYDeMatteoRP. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg2001;234:507517; discussion 517-509.

    • Search Google Scholar
    • Export Citation
  • 58.

    MatsuoKRochaFGItoK. The Blumgart preoperative staging system for hilar cholangiocarcinoma: analysis of resectability and outcomes in 380 patients. J Am Coll Surg2012;215:343355.

    • Search Google Scholar
    • Export Citation
  • 59.

    MillerGSchwartzLHD’AngelicaM. The use of imaging in the diagnosis and staging of hepatobiliary malignancies. Surg Oncol Clin N Am2007;16:343368.

    • Search Google Scholar
    • Export Citation
  • 60.

    AljiffryMWalshMJMolinariM. Advances in diagnosis, treatment and palliation of cholangiocarcinoma: 1990-2009. World J Gastroenterol2009;15:42404262.

    • Search Google Scholar
    • Export Citation
  • 61.

    SainaniNICatalanoOAHolalkereNS. Cholangiocarcinoma: current and novel imaging techniques. Radiographics2008;28:12631287.

  • 62.

    HalefogluAM. Magnetic resonance cholangiopancreatography: a useful tool in the evaluation of pancreatic and biliary disorders. World J Gastroenterol2007;13:25292534.

    • Search Google Scholar
    • Export Citation
  • 63.

    HekimogluKUstundagYDusakA. MRCP vs. ERCP in the evaluation of biliary pathologies: review of current literature. J Dig Dis2008;9:162169.

    • Search Google Scholar
    • Export Citation
  • 64.

    VoglTJSchwarzWOHellerM. Staging of Klatskin tumours (hilar cholangiocarcinomas): comparison of MR cholangiography, MR imaging, and endoscopic retrograde cholangiography. Eur Radiol2006;16:23172325.

    • Search Google Scholar
    • Export Citation
  • 65.

    HyodoTKumanoSKushihataF. CT and MR cholangiography: advantages and pitfalls in perioperative evaluation of biliary tree. Br J Radiol2012;85:887896.

    • Search Google Scholar
    • Export Citation
  • 66.

    KimJYKimMHLeeTY. Clinical role of 18F-FDG PET-CT in suspected and potentially operable cholangiocarcinoma: a prospective study compared with conventional imaging. Am J Gastroenterol2008;103:11451151.

    • Search Google Scholar
    • Export Citation
  • 67.

    RuysATBenninkRJvan WestreenenHL. FDG-positron emission tomography/computed tomography and standardized uptake value in the primary diagnosis and staging of hilar cholangiocarcinoma. HPB (Oxford)2011;13:256262.

    • Search Google Scholar
    • Export Citation
  • 68.

    NakagohriTAsanoTKinoshitaH. Aggressive surgical resection for hilar-invasive and peripheral intrahepatic cholangiocarcinoma. World J Surg2003;27:289293.

    • Search Google Scholar
    • Export Citation
  • 69.

    KonstadoulakisMMRoayaieSGomatosIP. Fifteen-year, single-center experience with the surgical management of intrahepatic cholangiocarcinoma: operative results and long-term outcome. Surgery2008;143:366374.

    • Search Google Scholar
    • Export Citation
  • 70.

    PaikKYJungJCHeoJS. What prognostic factors are important for resected intrahepatic cholangiocarcinoma?J Gastroenterol Hepatol2008;23:766770.

    • Search Google Scholar
    • Export Citation
  • 71.

    LangHSotiropoulosGCSgourakisG. Operations for intrahepatic cholangiocarcinoma: single-institution experience of 158 patients. J Am Coll Surg2009;208:218228.

    • Search Google Scholar
    • Export Citation
  • 72.

    MurakamiYUemuraKSudoT. Prognostic factors after surgical resection for intrahepatic, hilar, and distal cholangiocarcinoma. Ann Surg Oncol2011;18:651658.

    • Search Google Scholar
    • Export Citation
  • 73.

    RiberoDPinnaADGuglielmiA. Surgical Approach for long-term survival of patients with intrahepatic cholangiocarcinoma: a multi-institutional analysis of 434 patients. Arch Surg2012;147:11071113.

    • Search Google Scholar
    • Export Citation
  • 74.

    TamandlDHerbergerBGruenbergerB. Influence of hepatic resection margin on recurrence and survival in intrahepatic cholangiocarcinoma. Ann Surg Oncol2008;15:27872794.

    • Search Google Scholar
    • Export Citation
  • 75.

    FargesOFuksDBoleslawskiE. Influence of surgical margins on outcome in patients with intrahepatic cholangiocarcinoma: a multicenter study by the AFC-IHCC-2009 study group. Ann Surg2011;254:824829; discussion 830.

    • Search Google Scholar
    • Export Citation
  • 76.

    CarpizoDRD’AngelicaM. Management and extent of resection for intrahepatic cholangiocarcinoma. Surg Oncol Clin N Am2009;18:289305viii-ix.

    • Search Google Scholar
    • Export Citation
  • 77.

    GoereDWagholikarGDPessauxP. Utility of staging laparoscopy in subsets of biliary cancers: laparoscopy is a powerful diagnostic tool in patients with intrahepatic and gallbladder carcinoma. Surg Endosc2006;20:721725.

    • Search Google Scholar
    • Export Citation
  • 78.

    JosephSConnorSGardenOJ. Staging laparoscopy for cholangiocarcinoma. HPB (Oxford)2008;10:116119.

  • 79.

    ShimadaMYamashitaYAishimaS. Value of lymph node dissection during resection of intrahepatic cholangiocarcinoma. Br J Surg2001;88:14631466.

    • Search Google Scholar
    • Export Citation
  • 80.

    ChoiSBKimKSChoiJY. The prognosis and survival outcome of intrahepatic cholangiocarcinoma following surgical resection: association of lymph node metastasis and lymph node dissection with survival. Ann Surg Oncol2009;16:30483056.

    • Search Google Scholar
    • Export Citation
  • 81.

    ClarkCJWood-WentzCMReid-LombardoKM. Lymphadenectomy in the staging and treatment of intrahepatic cholangiocarcinoma: a population-based study using the National Cancer Institute SEER database. HPB (Oxford)2011;13:612620.

    • Search Google Scholar
    • Export Citation
  • 82.

    MorineYShimadaMUtsunomiyaT. Clinical impact of lymph node dissection in surgery for peripheral-type intrahepatic cholangiocarcinoma. Surg Today2012;42:147151.

    • Search Google Scholar
    • Export Citation
  • 83.

    FisherSBPatelSHKoobyDA. Lymphovascular and perineural invasion as selection criteria for adjuvant therapy in intrahepatic cholangiocarcinoma: a multi-institution analysis. HPB (Oxford)2012;14:514522.

    • Search Google Scholar
    • Export Citation
  • 84.

    HyderOHatzarasISotiropoulosGC. Recurrence after operative management of intrahepatic cholangiocarcinoma. Surgery2013;153:811818.

  • 85.

    RiberoDRossoSPinnaAD. Postoperative nomogram for predicting survival after resection for intrahepatic cholangiocarcinoma [abstract]. J Clin Oncol2013;31(Suppl):Abstract 4129.

    • Search Google Scholar
    • Export Citation
  • 86.

    CarrafielloGLaganaDCottaE. Radiofrequency ablation of intrahepatic cholangiocarcinoma: preliminary experience. Cardiovasc Intervent Radiol2010;33:835839.

    • Search Google Scholar
    • Export Citation
  • 87.

    KimJHWonHJShinYM. Radiofrequency ablation for the treatment of primary intrahepatic cholangiocarcinoma. AJR Am J Roentgenol2011;196:W205209.

    • Search Google Scholar
    • Export Citation
  • 88.

    KieferMVAlbertMMcNallyM. Chemoembolization of intrahepatic cholangiocarcinoma with cisplatinum, doxorubicin, mitomycin C, ethiodol, and polyvinyl alcohol: a 2-center study. Cancer2011;117:14981505.

    • Search Google Scholar
    • Export Citation
  • 89.

    KuhlmannJBEuringerWSpangenbergHC. Treatment of unresectable cholangiocarcinoma: conventional transarterial chemoembolization compared with drug eluting bead-transarterial chemoembolization and systemic chemotherapy. Eur J Gastroenterol Hepatol2012;24:437443.

    • Search Google Scholar
    • Export Citation
  • 90.

    HyderOMarshJWSalemR. Intra-arterial therapy for advanced intrahepatic cholangiocarcinoma: a multi-institutional analysis. Ann Surg Oncol2013;20:37793786.

    • Search Google Scholar
    • Export Citation
  • 91.

    PoggiGQuarettiPMinoiaC. Transhepatic arterial chemoembolization with oxaliplatin-eluting microspheres (OEM-TACE) for unresectable hepatic tumors. Anticancer Res2008;28:38353842.

    • Search Google Scholar
    • Export Citation
  • 92.

    SchiffmanSCMetzgerTDubelG. Precision hepatic arterial irinotecan therapy in the treatment of unresectable intrahepatic cholangiocellular carcinoma: optimal tolerance and prolonged overall survival. Ann Surg Oncol2011;18:431438.

    • Search Google Scholar
    • Export Citation
  • 93.

    IbrahimSMMulcahyMFLewandowskiRJ. Treatment of unresectable cholangiocarcinoma using yttrium-90 microspheres: results from a pilot study. Cancer2008;113:21192128.

    • Search Google Scholar
    • Export Citation
  • 94.

    SaxenaABesterLChuaTC. Yttrium-90 radiotherapy for unresectable intrahepatic cholangiocarcinoma: a preliminary assessment of this novel treatment option. Ann Surg Oncol2010;17:484491.

    • Search Google Scholar
    • Export Citation
  • 95.

    WijlemansJWVan ErpecumKJLamMG. Trans-arterial (90)yttrium radioembolization for patients with unresectable tumors originating from the biliary tree. Ann Hepatol2011;10:349354.

    • Search Google Scholar
    • Export Citation
  • 96.

    HoffmannRTPaprottkaPMSchonA. Transarterial hepatic yttrium-90 radioembolization in patients with unresectable intrahepatic cholangiocarcinoma: factors associated with prolonged survival. Cardiovasc Intervent Radiol2012;35:105116.

    • Search Google Scholar
    • Export Citation
  • 97.

    RafiSPiduruSMEl-RayesB. Yttrium-90 radioembolization for unresectable standard-chemorefractory intrahepatic cholangiocarcinoma: survival, efficacy, and safety study. Cardiovasc Intervent Radiol2013;36:440448.

    • Search Google Scholar
    • Export Citation
  • 98.

    MouliSMemonKBakerT. Yttrium-90 radioembolization for intrahepatic cholangiocarcinoma: safety, response, and survival analysis. J Vasc Interv Radiol2013;24:12271234.

    • Search Google Scholar
    • Export Citation
  • 99.

    OrtnerMECacaKBerrF. Successful photodynamic therapy for nonresectable cholangiocarcinoma: a randomized prospective study. Gastroenterology2003;125:13551363.

    • Search Google Scholar
    • Export Citation
  • 100.

    ZoepfTJakobsRArnoldJC. Palliation of nonresectable bile duct cancer: improved survival after photodynamic therapy. Am J Gastroenterol2005;100:24262430.

    • Search Google Scholar
    • Export Citation
  • 101.

    MambriniAGuglielmiAPacettiP. Capecitabine plus hepatic intra-arterial epirubicin and cisplatin in unresectable biliary cancer: a phase II study. Anticancer Res2007;27:30093013.

    • Search Google Scholar
    • Export Citation
  • 102.

    ShitaraKIkamiIMunakataM. Hepatic arterial infusion of mitomycin C with degradable starch microspheres for unresectable intrahepatic cholangiocarcinoma. Clin Oncol (R Coll Radiol)2008;20:241246.

    • Search Google Scholar
    • Export Citation
  • 103.

    InabaYAraiYYamauraH. Phase I/II study of hepatic arterial infusion chemotherapy with gemcitabine in patients with unresectable intrahepatic cholangiocarcinoma (JIVROSG-0301). Am J Clin Oncol2011;34:5862.

    • Search Google Scholar
    • Export Citation
  • 104.

    KemenyNESchwartzLGonenM. Treating primary liver cancer with hepatic arterial infusion of floxuridine and dexamethasone: does the addition of systemic bevacizumab improve results?Oncology2011;80:153159.

    • Search Google Scholar
    • Export Citation
  • 105.

    AkamatsuNSugawaraYHashimotoD. Surgical strategy for bile duct cancer: advances and current limitations. World J Clin Oncol2011;2:94107.

    • Search Google Scholar
    • Export Citation
  • 106.

    QiaoQLZhangTPGuoJC. Prognostic factors after pancreatoduodenectomy for distal bile duct cancer. Am Surg2011;77:14451448.

  • 107.

    SchwarzRESmithDD. Lymph node dissection impact on staging and survival of extrahepatic cholangiocarcinomas, based on U.S. population data. J Gastrointest Surg2007;11:158165.

    • Search Google Scholar
    • Export Citation
  • 108.

    ItoKItoHAllenPJ. Adequate lymph node assessment for extrahepatic bile duct adenocarcinoma. Ann Surg2010;251:675681.

  • 109.

    NishioHNaginoMNimuraY. Surgical management of hilar cholangiocarcinoma: the Nagoya experience. HPB (Oxford)2005;7:259262.

  • 110.

    ItoFAgniRRettammelRJ. Resection of hilar cholangiocarcinoma: concomitant liver resection decreases hepatic recurrence. Ann Surg2008;248:273279.

    • Search Google Scholar
    • Export Citation
  • 111.

    van GulikTMKloekJJRuysAT. Multidisciplinary management of hilar cholangiocarcinoma (Klatskin tumor): extended resection is associated with improved survival. Eur J Surg Oncol2011;37:6571.

    • Search Google Scholar
    • Export Citation
  • 112.

    ChengQBYiBWangJH. Resection with total caudate lobectomy confers survival benefit in hilar cholangiocarcinoma of Bismuth type III and IV. Eur J Surg Oncol2012;38:11971203.

    • Search Google Scholar
    • Export Citation
  • 113.

    ChoMSKimSHParkSW. Surgical outcomes and predicting factors of curative resection in patients with hilar cholangiocarcinoma: 10-year single-institution experience. J Gastrointest Surg2012;16:16721679.

    • Search Google Scholar
    • Export Citation
  • 114.

    LeeSGSongGWHwangS. Surgical treatment of hilar cholangiocarcinoma in the new era: the Asan experience. J Hepatobiliary Pancreat Sci2010;17:476489.

    • Search Google Scholar
    • Export Citation
  • 115.

    de JongMCMarquesHClaryBM. The impact of portal vein resection on outcomes for hilar cholangiocarcinoma: a multi-institutional analysis of 305 cases. Cancer2012;118:47374747.

    • Search Google Scholar
    • Export Citation
  • 116.

    WuXSDongPGuJ. Combined portal vein resection for hilar cholangiocarcinoma: a meta-analysis of comparative studies. J Gastrointest Surg2013;17:11071115.

    • Search Google Scholar
    • Export Citation
  • 117.

    ConnorSBarronEWigmoreSJ. The utility of laparoscopic assessment in the preoperative staging of suspected hilar cholangiocarcinoma. J Gastrointest Surg2005;9:476480.

    • Search Google Scholar
    • Export Citation
  • 118.

    WeberSMDeMatteoRPFongY. Staging laparoscopy in patients with extrahepatic biliary carcinoma. Analysis of 100 patients. Ann Surg2002;235:392399.

    • Search Google Scholar
    • Export Citation
  • 119.

    NimuraY. Preoperative biliary drainage before resection for cholangiocarcinoma (Pro). HPB (Oxford)2008;10:130133.

  • 120.

    KennedyTJYoppAQinY. Role of preoperative biliary drainage of liver remnant prior to extended liver resection for hilar cholangiocarcinoma. HPB (Oxford)2009;11:445451.

    • Search Google Scholar
    • Export Citation
  • 121.

    LiuFLiYWeiYLiB. Preoperative biliary drainage before resection for hilar cholangiocarcinoma: whether or not? A systematic review. Dig Dis Sci2011;56:663672.

    • Search Google Scholar
    • Export Citation
  • 122.

    FargesORegimbeauJMFuksD. Multicentre European study of preoperative biliary drainage for hilar cholangiocarcinoma. Br J Surg2013;100:274283.

    • Search Google Scholar
    • Export Citation
  • 123.

    AbulkhirALimongelliPHealeyAJ. Preoperative portal vein embolization for major liver resection: a meta-analysis. Ann Surg2008;247:4957.

    • Search Google Scholar
    • Export Citation
  • 124.

    ShindohJVautheyJNZimmittiG. Analysis of the efficacy of portal vein embolization for patients with extensive liver malignancy and very low future liver remnant volume, including a comparison with the associating liver partition with portal vein ligation for staged hepatectomy approach. J Am Coll Surg2013;217:126133.

    • Search Google Scholar
    • Export Citation
  • 125.

    DavidsPHGroenAKRauwsEA. Randomised trial of self-expanding metal stents versus polyethylene stents for distal malignant biliary obstruction. Lancet1992;340:14881492.

    • Search Google Scholar
    • Export Citation
  • 126.

    PratFChapatODucotB. A randomized trial of endoscopic drainage methods for inoperable malignant strictures of the common bile duct. Gastrointest Endosc1998;47:17.

    • Search Google Scholar
    • Export Citation
  • 127.

    AbrahamNSBarkunJSBarkunAN. Palliation of malignant biliary obstruction: a prospective trial examining impact on quality of life. Gastrointest Endosc2002;56:835841.

    • Search Google Scholar
    • Export Citation
  • 128.

    PaikWHParkYSHwangJH. Palliative treatment with self-expandable metallic stents in patients with advanced type III or IV hilar cholangiocarcinoma: a percutaneous versus endoscopic approach. Gastrointest Endosc2009;69:5562.

    • Search Google Scholar
    • Export Citation
  • 129.

    RoblesRFiguerasJTurrionVS. Spanish experience in liver transplantation for hilar and peripheral cholangiocarcinoma. Ann Surg2004;239:265271.

    • Search Google Scholar
    • Export Citation
  • 130.

    BeckerNSRodriguezJABarshesNR. Outcomes analysis for 280 patients with cholangiocarcinoma treated with liver transplantation over an 18-year period. J Gastrointest Surg2008;12:117122.

    • Search Google Scholar
    • Export Citation
  • 131.

    KaiserGMSotiropoulosGCJauchKW. Liver transplantation for hilar cholangiocarcinoma: a German survey. Transplant Proc2008;40:31913193.

    • Search Google Scholar
    • Export Citation
  • 132.

    FrimanSFossAIsoniemiH. Liver transplantation for cholangiocarcinoma: selection is essential for acceptable results. Scand J Gastroenterol2011;46:370375.

    • Search Google Scholar
    • Export Citation
  • 133.

    Darwish MuradSKimWRHarnoisDM. Efficacy of neoadjuvant chemoradiation, followed by liver transplantation, for perihilar cholangiocarcinoma at 12 US centers. Gastroenterology2012;143:8898.

    • Search Google Scholar
    • Export Citation
  • 134.

    PanjalaCNguyenJHAl-HajjajAN. Impact of neoadjuvant chemoradiation on the tumor burden before liver transplantation for unresectable cholangiocarcinoma. Liver Transpl2012;18:594601.

    • Search Google Scholar
    • Export Citation
  • 135.

    DuignanSMaguireDRavichandCS. Neoadjuvant chemoradiotherapy followed by liver transplantation for unresectable cholangiocarcinoma: a single-centre national experience. HPB (Oxford)2014;16:9198.

    • Search Google Scholar
    • Export Citation
  • 136.

    ReaDJHeimbachJKRosenCB. Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma. Ann Surg2005;242:451458.

    • Search Google Scholar
    • Export Citation
  • 137.

    HongJCJonesCMDuffyJP. Comparative analysis of resection and liver transplantation for intrahepatic and hilar cholangiocarcinoma: a 24-year experience in a single center. Arch Surg2011;146:683689.

    • Search Google Scholar
    • Export Citation
  • 138.

    CeredaSBelliCReniM. Adjuvant treatment in biliary tract cancer: to treat or not to treat?World J Gastroenterol2012;18:25912596.

  • 139.

    GlazerESLiuPAbdallaEK. Neither neoadjuvant nor adjuvant therapy increases survival after biliary tract cancer resection with wide negative margins. J Gastrointest Surg2012;16:16661671.

    • Search Google Scholar
    • Export Citation
  • 140.

    HorganAMAmirEWalterTKnoxJJ. Adjuvant therapy in the treatment of biliary tract cancer: a systematic review and meta-analysis. J Clin Oncol2012;30:19341940.

    • Search Google Scholar
    • Export Citation
  • 141.

    TakadaTAmanoHYasudaH. Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma. Cancer2002;95:16851695.

    • Search Google Scholar
    • Export Citation
  • 142.

    KayaharaMNagakawaT. Recent trends of gallbladder cancer in Japan: an analysis of 4,770 patients. Cancer2007;110:572580.

  • 143.

    GoldDGMillerRCHaddockMG. Adjuvant therapy for gallbladder carcinoma: the Mayo Clinic Experience. Int J Radiat Oncol Biol Phys2009;75:150155.

    • Search Google Scholar
    • Export Citation
  • 144.

    ChoSYKimSHParkSJ. Adjuvant chemoradiation therapy in gallbladder cancer. J Surg Oncol2010;102:8793.

  • 145.

    KimKChieEKJangJY. Postoperative chemoradiotherapy for gallbladder cancer. Strahlenther Onkol2012;188:388392.

  • 146.

    HughesMAFrassicaDAYeoCJ. Adjuvant concurrent chemoradiation for adenocarcinoma of the distal common bile duct. Int J Radiat Oncol Biol Phys2007;68:178182.

    • Search Google Scholar
    • Export Citation
  • 147.

    NelsonJWGhafooriAPWillettCG. Concurrent chemoradiotherapy in resected extrahepatic cholangiocarcinoma. Int J Radiat Oncol Biol Phys2009;73:148153.

    • Search Google Scholar
    • Export Citation
  • 148.

    LimKHOhDYChieEK. Adjuvant concurrent chemoradiation therapy (CCRT) alone versus CCRT followed by adjuvant chemotherapy: which is better in patients with radically resected extrahepatic biliary tract cancer?: a non-randomized, single center study. BMC Cancer2009;9:345.

    • Search Google Scholar
    • Export Citation
  • 149.

    KimTHHanSSParkSJ. Role of adjuvant chemoradiotherapy for resected extrahepatic biliary tract cancer. Int J Radiat Oncol Biol Phys2011;81:e853859.

    • Search Google Scholar
    • Export Citation
  • 150.

    BorgheroYCraneCHSzklarukJ. Extrahepatic bile duct adenocarcinoma: patients at high-risk for local recurrence treated with surgery and adjuvant chemoradiation have an equivalent overall survival to patients with standard-risk treated with surgery alone. Ann Surg Oncol2008;15:31473156.

    • Search Google Scholar
    • Export Citation
  • 151.

    ParkJHChoiEKAhnSD. Postoperative chemoradiotherapy for extrahepatic bile duct cancer. Int J Radiat Oncol Biol Phys2011;79:696704.

  • 152.

    DasPWolffRAAbbruzzeseJL. Concurrent capecitabine and upper abdominal radiation therapy is well tolerated. Radiat Oncol2006;1:4141.

  • 153.

    LinLLPicusJDrebinJA. A phase II study of alternating cycles of split course radiation therapy and gemcitabine chemotherapy for inoperable pancreatic or biliary tract carcinoma. Am J Clin Oncol2005;28:234241.

    • Search Google Scholar
    • Export Citation
  • 154.

    ParkJKimMHKimKP. Natural history and prognostic factors of advanced cholangiocarcinoma without surgery, chemotherapy, or radiotherapy: a large-scale observational study. Gut Liver2009;3:298305.

    • Search Google Scholar
    • Export Citation
  • 155.

    GlimeliusBHoffmanKSjodenPO. Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer. Ann Oncol1996;7:593600.

    • Search Google Scholar
    • Export Citation
  • 156.

    SharmaADwaryADMohantiBK. Best supportive care compared with chemotherapy for unresectable gall bladder cancer: a randomized controlled study. J Clin Oncol2010;28:45814586.

    • Search Google Scholar
    • Export Citation
  • 157.

    HezelAFZhuAX. Systemic therapy for biliary tract cancers. Oncologist2008;13:415423.

  • 158.

    GeynismanDMCatenacciDV. Toward personalized treatment of advanced biliary tract cancers. Discov Med2012;14:4157.

  • 159.

    EckelFSchmidRM. Chemotherapy in advanced biliary tract carcinoma: a pooled analysis of clinical trials. Br J Cancer2007;96:896902.

  • 160.

    YonemotoNFuruseJOkusakaT. A multi-center retrospective analysis of survival benefits of chemotherapy for unresectable biliary tract cancer. Jpn J Clin Oncol2007;37:843851.

    • Search Google Scholar
    • Export Citation
  • 161.

    KornekGVSchuellBLaengleF. Mitomycin C in combination with capecitabine or biweekly high-dose gemcitabine in patients with advanced biliary tract cancer: a randomised phase II trial. Ann Oncol2004;15:478483.

    • Search Google Scholar
    • Export Citation
  • 162.

    DucreuxMVan CutsemEVan LaethemJL. A randomised phase II trial of weekly high-dose 5-fluorouracil with and without folinic acid and cisplatin in patients with advanced biliary tract carcinoma: results of the 40955 EORTC trial. Eur J Cancer2005;41:398403.

    • Search Google Scholar
    • Export Citation
  • 163.

    ValleJWasanHPalmerDH. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med2010;362:12731281.

  • 164.

    OkusakaTNakachiKFukutomiA. Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan. Br J Cancer2010;103:469474.

    • Search Google Scholar
    • Export Citation
  • 165.

    DovalDCSekhonJSGuptaSK. A phase II study of gemcitabine and cisplatin in chemotherapy-naive, unresectable gall bladder cancer. Br J Cancer2004;90:15161520.

    • Search Google Scholar
    • Export Citation
  • 166.

    ThongprasertSNapapanSCharoentumCMoonprakanS. Phase II study of gemcitabine and cisplatin as first-line chemotherapy in inoperable biliary tract carcinoma. Ann Oncol2005;16:279281.

    • Search Google Scholar
    • Export Citation
  • 167.

    GiulianiFGebbiaVMaielloE. Gemcitabine and cisplatin for inoperable and/or metastatic biliary tree carcinomas: a multicenter phase II study of the Gruppo Oncologico dell’Italia Meridionale (GOIM). Ann Oncol2006;17Suppl 7:7377.

    • Search Google Scholar
    • Export Citation
  • 168.

    LeeJKimTYLeeMA. Phase II trial of gemcitabine combined with cisplatin in patients with inoperable biliary tract carcinomas. Cancer Chemother Pharmacol2008;61:4752.

    • Search Google Scholar
    • Export Citation
  • 169.

    MeyerhardtJAZhuAXStuartK. Phase-II study of gemcitabine and cisplatin in patients with metastatic biliary and gallbladder cancer. Dig Dis Sci2008;53:564570.

    • Search Google Scholar
    • Export Citation
  • 170.

    AndreTReyes-VidalJMFartouxL. Gemcitabine and oxaliplatin in advanced biliary tract carcinoma: a phase II study. Br J Cancer2008;99:862867.

    • Search Google Scholar
    • Export Citation
  • 171.

    HarderJRieckenBKummerO. Outpatient chemotherapy with gemcitabine and oxaliplatin in patients with biliary tract cancer. Br J Cancer2006;95:848852.

    • Search Google Scholar
    • Export Citation
  • 172.

    KimHJLeeNSLeeSC. A phase II study of gemcitabine in combination with oxaliplatin as first-line chemotherapy in patients with inoperable biliary tract cancer. Cancer Chemother Pharmacol2009;64:371377.

    • Search Google Scholar
    • Export Citation
  • 173.

    JangJSLimHYHwangIG. Gemcitabine and oxaliplatin in patients with unresectable biliary cancer including gall bladder cancer: a Korean Cancer Study Group phase II trial. Cancer Chemother Pharmacol2010;65:641647.

    • Search Google Scholar
    • Export Citation
  • 174.

    AlbertsSRAl-KhatibHMahoneyMR. Gemcitabine, 5-fluorouracil, and leucovorin in advanced biliary tract and gallbladder carcinoma: a North Central Cancer Treatment Group phase II trial. Cancer2005;103:111118.

    • Search Google Scholar
    • Export Citation
  • 175.

    ChoJYPaikYHChangYS. Capecitabine combined with gemcitabine (CapGem) as first-line treatment in patients with advanced/metastatic biliary tract carcinoma. Cancer2005;104:27532758.

    • Search Google Scholar
    • Export Citation
  • 176.

    KnoxJJHedleyDOzaA. Combining gemcitabine and capecitabine in patients with advanced biliary cancer: a phase II trial. J Clin Oncol2005;23:23322338.

    • Search Google Scholar
    • Export Citation
  • 177.

    RiechelmannRPTownsleyCAChinSN. Expanded phase II trial of gemcitabine and capecitabine for advanced biliary cancer. Cancer2007;110:13071312.

    • Search Google Scholar
    • Export Citation
  • 178.

    KoeberleDSalettiPBornerM. Patient-reported outcomes of patients with advanced biliary tract cancers receiving gemcitabine plus capecitabine: a multicenter, phase II trial of the Swiss Group for Clinical Cancer Research. J Clin Oncol2008;26:37023708.

    • Search Google Scholar
    • Export Citation
  • 179.

    IqbalSRankinCLenzHJ. A phase II trial of gemcitabine and capecitabine in patients with unresectable or metastatic gallbladder cancer or cholangiocarcinoma: Southwest Oncology Group study S0202. Cancer Chemother Pharmacol2011;68:15951602.

    • Search Google Scholar
    • Export Citation
  • 180.

    NehlsOKlumpBArkenauHT. Oxaliplatin, fluorouracil and leucovorin for advanced biliary system adenocarcinomas: a prospective phase II trial. Br J Cancer2002;87:702704.

    • Search Google Scholar
    • Export Citation
  • 181.

    NehlsOOettleHHartmannJT. Capecitabine plus oxaliplatin as first-line treatment in patients with advanced biliary system adenocarcinoma: a prospective multicentre phase II trial. Br J Cancer2008;98:309315.

    • Search Google Scholar
    • Export Citation
  • 182.

    KimTWChangHMKangHJ. Phase II study of capecitabine plus cisplatin as first-line chemotherapy in advanced biliary cancer. Ann Oncol2003;14:11151120.

    • Search Google Scholar
    • Export Citation
  • 183.

    KobayashiKTsujiAMoritaS. A phase II study of LFP therapy (5-FU (5-fluorourasil) continuous infusion (CVI) and low-dose consecutive (Cisplatin) CDDP) in advanced biliary tract carcinoma. BMC Cancer2006;6:121121.

    • Search Google Scholar
    • Export Citation
  • 184.

    RaoSCunninghamDHawkinsRE. Phase III study of 5FU, etoposide and leucovorin (FELV) compared to epirubicin, cisplatin and 5FU (ECF) in previously untreated patients with advanced biliary cancer. Br J Cancer2005;92:16501654.

    • Search Google Scholar
    • Export Citation
  • 185.

    YamashitaYTaketomiAFukuzawaK. Gemcitabine combined with 5-fluorouracil and cisplatin (GFP) in patients with advanced biliary tree cancers: a pilot study. Anticancer Res2006;26:771775.

    • Search Google Scholar
    • Export Citation
  • 186.

    WagnerADBuechner-SteudelPMoehlerM. Gemcitabine, oxaliplatin and 5-FU in advanced bile duct and gallbladder carcinoma: two parallel, multicentre phase-II trials. Br J Cancer2009;101:18461852.

    • Search Google Scholar
    • Export Citation
  • 187.

    SohalDPMykulowyczKUeharaT. A phase II trial of gemcitabine, irinotecan and panitumumab in advanced cholangiocarcinoma. Ann Oncol2013;24:30613065.

    • Search Google Scholar
    • Export Citation
  • 188.

    GhafooriAPNelsonJWWillettCG. Radiotherapy in the treatment of patients with unresectable extrahepatic cholangiocarcinoma. Int J Radiat Oncol Biol Phys2011;81:654659.

    • Search Google Scholar
    • Export Citation
  • 189.

    MacdonaldOKCraneCH. Palliative and postoperative radiotherapy in biliary tract cancer. Surg Oncol Clin N Am2002;11:941954.

  • 190.

    CzitoBGAnscherMSWillettCG. Radiation therapy in the treatment of cholangiocarcinoma. Oncology (Williston Park)2006;20:873884.

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 251 231 10
PDF Downloads 69 62 2
EPUB Downloads 0 0 0